Our research focuses on the mechanisms of decreased insulin production in type 2 diabetes. We have described an inflammatory process underlying the defect of insulin production in this condition. On the basis of this we conducted clinical studies. This program has now entered the phase 3 of clinical development. The objective of the present project is to uncover additional roles of the immune system in the regulation of insulin secretion during adaptation to obesity and its contribution to diabetes